VEGF: necessary to prevent motoneuron degeneration, sufficient to treat ALS?

Diether Lambrechts; Erik Storkebaum; Peter Carmeliet

doi:10.1016/j.molmed.2004.04.004

Related publications

Article2004

Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS

Erik Storkebaum, Diether Lambrechts, Mieke Dewerchin, Paz Moreno-Murciano, Saskia Appelmans, Hideyasu Oh, Philip Van Damme, Bart P. F. Rutten, W.Y. Man, Maria De Mol, Sabine Wyns, David Manka, Kristel Vermeulen, Ludo Van Den Bosch, Nico Mertens, Christoph Schmitz, Wim Robberecht, Edward M. Conway, D Collen, Lieve Moons, Peter Carmeliet

Article2003

The effect of Vascular Endothelial Growth Factor (VEGF) on Motoneuron Degeneration

Ludo Van Den Bosch, Erik Storkebaum, V. Vleminckx, Lieve Moons, Ludo Vanopdenbosch, Wendy Scheveneels, Peter Carmeliet, Marc M. Van Hulle, Wim Robberecht

Article2005

A novel role for VEGF-B in motorneuron degeneration in ALS

Diether Lambrechts, Peggy Lafuste, Désiré Collen, Mieke Dewerchin, Lieve Moons, Peter Carmeliet

Dataset

Faculty Opinions recommendation of Caspase-12 cleavage and increased oxidative stress during motoneuron degeneration in transgenic mouse model of ALS.

George Perry

Article2004

Treatment of an aggressive form of motor neuron degeneration by VEGF protein and gene transfer in ALS animal models

Erik Storkebaum, Diether Lambrechts, Nebojša Arsić, Mieke Dewerchin, Philip Van Damme, Ludo Van Den Bosch, Wim Robberecht, Myriam Baes, Désiré Collen, Mauro Giacca, Lieve Moons, Peter Carmeliet